Vanguard Group’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$93M Buy
7,578,293
+61,665
+0.8% +$757K ﹤0.01% 1857
2025
Q1
$165M Sell
7,516,628
-64,339
-0.8% -$1.41M ﹤0.01% 1562
2024
Q4
$172M Sell
7,580,967
-162,961
-2% -$3.7M ﹤0.01% 1611
2024
Q3
$141M Sell
7,743,928
-28,826
-0.4% -$524K ﹤0.01% 1722
2024
Q2
$226M Buy
7,772,754
+791,987
+11% +$23.1M ﹤0.01% 1435
2024
Q1
$247M Sell
6,980,767
-32,026
-0.5% -$1.14M ﹤0.01% 1384
2023
Q4
$305M Sell
7,012,793
-147,061
-2% -$6.4M 0.01% 1275
2023
Q3
$273M Buy
7,159,854
+72,294
+1% +$2.76M 0.01% 1266
2023
Q2
$292M Buy
7,087,560
+62,137
+0.9% +$2.56M 0.01% 1262
2023
Q1
$403M Sell
7,025,423
-122,336
-2% -$7.02M 0.01% 1030
2022
Q4
$401M Buy
7,147,759
+218,153
+3% +$12.2M 0.01% 1007
2022
Q3
$294M Buy
6,929,606
+189,772
+3% +$8.04M 0.01% 1149
2022
Q2
$364M Buy
6,739,834
+185,727
+3% +$10M 0.01% 1047
2022
Q1
$421M Sell
6,554,107
-105,015
-2% -$6.75M 0.01% 1079
2021
Q4
$446M Sell
6,659,122
-13,264
-0.2% -$889K 0.01% 1076
2021
Q3
$457M Buy
6,672,386
+20,888
+0.3% +$1.43M 0.01% 1030
2021
Q2
$454M Buy
6,651,498
+44,050
+0.7% +$3.01M 0.01% 1059
2021
Q1
$457M Buy
6,607,448
+132,907
+2% +$9.18M 0.01% 1011
2020
Q4
$420M Buy
6,474,541
+93,571
+1% +$6.07M 0.01% 971
2020
Q3
$301M Sell
6,380,970
-301,688
-5% -$14.2M 0.01% 1014
2020
Q2
$314M Sell
6,682,658
-150,929
-2% -$7.09M 0.01% 997
2020
Q1
$305M Buy
6,833,587
+182,888
+3% +$8.17M 0.01% 887
2019
Q4
$388M Sell
6,650,699
-143,184
-2% -$8.34M 0.01% 969
2019
Q3
$408M Buy
6,793,883
+354,746
+6% +$21.3M 0.02% 896
2019
Q2
$360M Buy
6,439,137
+144,122
+2% +$8.05M 0.01% 990
2019
Q1
$351M Buy
6,295,015
+93,205
+2% +$5.19M 0.01% 981
2018
Q4
$280M Buy
6,201,810
+82,621
+1% +$3.73M 0.01% 1028
2018
Q3
$403M Sell
6,119,189
-173,390
-3% -$11.4M 0.02% 904
2018
Q2
$405M Buy
6,292,579
+295,706
+5% +$19M 0.02% 891
2018
Q1
$332M Buy
5,996,873
+97,751
+2% +$5.41M 0.01% 969
2017
Q4
$282M Buy
5,899,122
+220,432
+4% +$10.5M 0.01% 1066
2017
Q3
$287M Buy
5,678,690
+183,796
+3% +$9.28M 0.01% 1030
2017
Q2
$300M Sell
5,494,894
-161,154
-3% -$8.78M 0.01% 979
2017
Q1
$238M Buy
5,656,048
+436,928
+8% +$18.4M 0.01% 1100
2016
Q4
$224M Buy
5,219,120
+178,214
+4% +$7.64M 0.01% 1096
2016
Q3
$208M Buy
5,040,906
+224,904
+5% +$9.28M 0.01% 1082
2016
Q2
$192M Buy
4,816,002
+267,550
+6% +$10.7M 0.01% 1079
2016
Q1
$153M Buy
4,548,452
+122,328
+3% +$4.12M 0.01% 1183
2015
Q4
$150M Buy
4,426,124
+118,854
+3% +$4.03M 0.01% 1181
2015
Q3
$128M Sell
4,307,270
-336,704
-7% -$10M 0.01% 1270
2015
Q2
$128M Buy
4,643,974
+434,927
+10% +$12M 0.01% 1363
2015
Q1
$106M Buy
4,209,047
+239,683
+6% +$6.04M 0.01% 1455
2014
Q4
$88M Buy
3,969,364
+106,113
+3% +$2.35M 0.01% 1507
2014
Q3
$78.4M Buy
3,863,251
+77,093
+2% +$1.56M 0.01% 1527
2014
Q2
$72.8M Buy
3,786,158
+92,661
+3% +$1.78M 0.01% 1618
2014
Q1
$69.4M Buy
3,693,497
+197,706
+6% +$3.72M 0.01% 1606
2013
Q4
$68.2M Buy
3,495,791
+486,824
+16% +$9.49M 0.01% 1583
2013
Q3
$49.5M Buy
3,008,967
+126,815
+4% +$2.09M ﹤0.01% 1725
2013
Q2
$43.2M Buy
+2,882,152
New +$43.2M ﹤0.01% 1726